Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that its QuantiFERON-TB Gold Plus test – the modern gold standard for latent tuberculosis (TB) detection – has been chosen for use in tenders initiated by the National Health System (NHS) in England as part of its national TB control initiatives. Compared […]
WALTHAM, Mass. –– PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its Vectra® 3 automated, high-throughput quantitative pathology imaging system. This solution’s new seven color multiplexing and visualization capabilities are designed to enable pathologists and oncologists conducting research to gain a […]
SAN DIEGO, CA — Human Longevity Inc. (HLI), the genomics based, informatics driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions. The San Diego-based company has 14 employees who will join HLI including Cypher CEO and […]
Melbourne, Australia: Trajan Scientific and Medical (Trajan) has announced the opening of a new Business Unit – Instruments, Sensors and Devices, to be located at the University of Adelaide’s Institute for Photonics and Advanced Sensing (IPAS). Along with the new capabilities existing on that site such as glass modification and extrusion, the new Business Unit […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced it has received clearance from theU.S. Food and Drug Administration (FDA) for new claims for its illumigene® Pertussis molecular amplification test. The upgraded test reduces the effect of inhibitors in biologic samples and significantly expands Meridian’s customer base by including specimens collected by ESwab™ (Copan Diagnostics, […]
NEW YORK, NY – Enzo Biochem, Inc. (NYSE: ENZ) announced that the New York State Department of Health has granted approval of Enzo Clinical Labs’ AmpiProbe-HCV ™ assay for the quantitative detection of Hepatitis C virus, clearing the way for Enzo to begin offering this assay to the market on a national basis. In addition, […]
LEXINGTON, Mass. – N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed a global agreement with WuXi NextCODE to provide clinical and scientific evidence for delivering the best personalized treatment options based on the results of WuXi NextCODE tumor-normal genome sequence interpretation, which identifies key driver […]
LGC, the international life sciences and measurement company, today announces that it has acquired Maine Standards Company, the leading provider of calibration verification materials for clinical laboratories in the US. The acquisition bolsters LGC’s growing portfolio of reference materials and proficiency testing (PT) schemes for the clinical market. Euan O’Sullivan, Managing Director of LGC’s Standards […]
Berlin, Germany, and Kremsmünster, Austria: The emerging field of rapid diagnostic tests is becoming increasingly important in a variety of applications. For infectious diseases, the time to diagnosis is a critical factor for ensuring successful management. This collaboration will focus on the development of new tests that will optimize patient care by providing sensitive and […]
Craigavon, N.I., UK, –– Almac Diagnostics announced that it had entered into a collaboration with Illumina, Inc. (NASDAQ: ILMN) to establish a framework for the development of next-generation sequencing (NGS)-based companion diagnostic assays. The collaboration enables Almac to develop next-generation sequencing (NGS) assays using the Illumina MiSeqDx® instrument, the first FDA-cleared IVD NGS system designed […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
